ArticleHemaSphere2023

Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies.

Sathej Gopalakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.